Rethinking dry eye disease: A perspective on clinical implications

Ocular Surface

Volumn 12, Issue 2 SUPPL., 2014, Pages

  Bron, Anthony J ^a   Tomlinson, Alan ^b   Foulks, Gary N ^c   Pepose, Jay S ^d   Baudouin, Christophe ^e   Geerling, Gerd ^f   Nichols, Kelly K ^g   Lemp, Michael A ^h  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY OF HOUSTON   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

Author keywords

Aqueous deficient dry eye disease; Dry eye disease; Inflammation; Meibomian gland dysfunction; Osmolarity; Point of care testing

Indexed keywords

CHEMOKINE; CORTICOSTEROID; CYTOKINE; DOXYCYCLINE; INTERLEUKIN 17; MOLECULAR MARKER; MUCIN; TOLL LIKE RECEPTOR;

BLINKING; CATARACT; CATARACT EXTRACTION; CLINICAL EXAMINATION; CONTACT LENS; DISEASE PREDISPOSITION; DRY EYE; ENVIRONMENTAL FACTOR; GLAUCOMA; HUMAN; INFLAMMATION; INTERFEROMETRY; MEIBOMIAN GLAND; NATURAL KILLER CELL; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PROTEOMICS; QUANTITATIVE ANALYSIS; REFRACTIVE SURGERY; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC DISEASE; T LYMPHOCYTE; TEAR FILM; TEAR OSMOLARITY; THICKNESS; DRY EYE SYNDROMES; KERATOCONJUNCTIVITIS SICCA; LACRIMAL FLUID; OSMOLARITY; PHYSIOLOGY;

BLINKING; DRY EYE SYNDROMES; HUMANS; KERATOCONJUNCTIVITIS SICCA; MEIBOMIAN GLANDS; OSMOLAR CONCENTRATION; TEARS;

EID: 84901390080     PISSN: 15420124     EISSN: 19375913     Source Type: Journal    
DOI: 10.1016/j.jtos.2014.02.002     Document Type: Review

References (298)

1. The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international dry eye WorkShop (2007). Ocul Surf 2007;5(2):75-92
2. Research in dry eye: Report of the research subcommittee of the international dry eye WorkShop (2007). Ocul Surf 2007;5(2):179-93
3. Design and conduct of clinical trials: Report of the clinical trials subcommittee of the international dry eye WorkShop (2007). Ocul Surf 2007;5(2):153-62
4. Methodologies to diagnose and monitor dry eye disease: Report of the diagnostic methodology subcommittee of the international dry eye WorkShop (2007). Ocul Surf 2007;5(2):108-52
5. The epidemiology of dry eye disease: Report of the epidemiology subcommittee of the international dry eye WorkShop (2007). Ocul Surf 2007;5(2):93-107
6. Management and therapy of dry eye disease: Report of the management and therapy subcommittee of the international dry eye Work-Shop (2007). Ocul Surf 2007;5(2):163-78
7. Stern ME, Gao J, Siemasko KF, et al. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 2004;78: 409-16 (Pubitemid 38183319)
8. Bron AJ. The doyne lecture: Reflections on the tears. Eye (Lond) 1997;11(Pt 5):583-602 (Pubitemid 27499810)
9. Mishima S, Gasset A, Klyce Jr SD, Baum JL. Determination of tear volume and tear flow. Invest Ophthalmol 1966;5(3):264-76
10. Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res 2002;21(6):555-76 (Pubitemid 35341511)
11. Gaffney EA, Tiffany JM, Yokoi N, Bron AJ. A mass and solute balance model for tear volume and osmolarity in the normal and the dry eye. Prog Retin Eye Res 2010;29(1):59-78
12. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res 2004;78(3):347-60 (Pubitemid 38183311)
13. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: Report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 2011;52(4):1938-78
14. Blackie CA, Korb DR. The diurnal secretory characteristics of individual meibomian glands. Cornea 2010;29(1):34-8
15. Chew CK, Hykin PG, Jansweijer C,Dikstein S, Tiffany JM, Bron AJ. The casual level ofmeibomian lipids in humans. Curr Eye Res 1993;12(3):255-9 (Pubitemid 23128143)
16. Chew CK, Jansweijer C, Tiffany JM, Dikstein S, Bron AJ. An instrument for quantifying meibomian lipid on the lid margin: The meibometer. Curr Eye Res 1993;12(3):247-54 (Pubitemid 23128142)
17. McDonald JE. Surface phenomena of the tear film. Am J Ophthalmol 1969;67(1):56-64
18. Korb DR, Greiner JV, Herman JP, et al. Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers. CLAO J 2002;28(4):211-6 (Pubitemid 38269643)
19. King-Smith PE, Fink BA, Hill RM, Koelling KW, Tiffany JM. The thickness of the tear film. Curr Eye Res 2004;29(4-5):357-68 (Pubitemid 40095021)
20. King-Smith PE, Fink BA, Fogt N, Nichols KK, Hill RM, Wilson GS. The thickness of the human precorneal tear film: Evidence from reflection spectra. Invest Ophthalmol Vis Sci 2000;41(11):3348-59
21. Holly FJ, Lemp MA. Wettability and wetting of corneal epithelium. Exp Eye Res 1971;11(2):239-50
22. Spurr-Michaud S, Argueso P, Gipson I. Assay of mucins in human tear fluid. Exp Eye Res 2007;84(5):939-50 (Pubitemid 46590136)
23. Gipson IK, Hori Y, Argueso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf 2004;2(2):131-48 (Pubitemid 41268494)
24. King-Smith PE, Hinel EA, Nichols JJ. Application of a novel interferometric method to investigate the relation between lipid layer thickness and tear film thinning. Invest Ophthalmol Vis Sci 2010;51(5): 2418-23
25. Tiffany JM. The lipid secretion of the meibomian glands. Adv Lipid Res 1987;22:1-62
26. Butovich IA. The meibomian puzzle: Combining pieces together. Prog Retin Eye Res 2009;28(6):483-98
27. Butovich IA, Millar TJ, Ham BM. Understanding and analyzing meibomian lipidsea review. Curr Eye Res 2008;33(5):405-20 (Pubitemid 351998839)
28. Butovich IA. On the presence of (O-acyl)-omega-hydroxy fatty acids and of their esters in human meibomian gland secretions. Invest Ophthalmol Vis Sci 2011;52(1):639-41
29. Millar TJ, Tragoulias ST, Anderton PJ, et al. The surface activity of purified ocular mucin at the air-liquid interface and interactions with meibomian lipids. Cornea 2006;25(1):91-100 (Pubitemid 43031156)
30. Green-Church KB, Butovich I, Willcox M, et al. The international workshop on meibomian gland dysfunction: Report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci 2011;52(4):1979-93
31. Garreis F, Gottschalt M, Schlorf T, et al. Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus. Invest Ophthalmol Vis Sci 2011;52(7):4914-22
32. Garreis F, Schlorf T, Worlitzsch D, et al. Roles of human betadefensins in innate immune defense at the ocular surface: Arming and alarming corneal and conjunctival epithelial cells. Histochem Cell Biol 2010;134(1):59-73
33. Garreis F, Gottschalt M, Paulsen FP. Antimicrobial peptides as a major part of the innate immune defense at the ocular surface. Dev Ophthalmol 2010;45:16-22
34. Paulsen FP, Berry MS. Mucins and TFF peptides of the tear film and lacrimal apparatus. Prog Histochem Cytochem 2006;41(1):1-53
35. Ni M, Tam C, Verma A, et al. Expression of surfactant protein D in human corneal epithelial cells is upregulated by pseudomonas aeruginosa. FEMS Immunol Med Microbiol 2008;54(2):177-84
36. Van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol 1981;26(2):84-96 (Pubitemid 11022563)
37. Norn MS. Dead, degenerate, and living cells in conjunctival fluid and mucous thread. Acta Ophthalmol (Copenh) 1969;47(5):1102-15
38. Bron AJ, Yokoi N, Gaffney EA, Tiffany JM. A solute gradient in the tear meniscus. I. A hypothesis to explain marx?s line. Ocul Surf 2011;9(2):70-91
39. Bron AJ, Yokoi N, Gaffney EA, Tiffany JM. A solute gradient in the tear meniscus. II. implications for lid margin disease, including meibomian gland dysfunction. Ocul Surf 2011;9(2):92-7
40. Yokoi N, Kinoshita S, Bron AJ, Tiffany JM, Sugita J, Inatomi T. Tear meniscus changes during cotton thread and schirmer testing. Invest Ophthalmol Vis Sci 2000;41(12):3748-53
41. Yokoi N, Bron AJ, Tiffany JM, Maruyama K, Komuro A, Kinoshita S. Relationship between tear volume and tear meniscus curvature. Arch Ophthalmol 2004;122(9):1265-9 (Pubitemid 39180845)
42. Mainstone JC, Bruce AS, Golding TR. Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res 1996;15(6):653-61 (Pubitemid 26276541)
43. Yokoi N, Bron A, Tiffany J, Brown N, Hsuan J, Fowler C. Reflective meniscometry: A non-invasive method to measure tear meniscus curvature. Br J Ophthalmol 1999;83(1):92-7 (Pubitemid 29106340)
44. Yokoi N, Bron AJ, Tiffany JM, Kinoshita S. Reflective meniscometry: A new field of dry eye assessment. Cornea 2000;19(3 Suppl):S37-43
45. Shen M, Li J, Wang J, et al. Upper and lower tear menisci in the diagnosis of dry eye. Invest Ophthalmol Vis Sci 2009;50(6):2722-6
46. Yokoi N, Komuro A. Non-invasive methods of assessing the tear film. Exp Eye Res 2004;78(3):399-407 (Pubitemid 38183318)
47. Naase T, Doughty MJ, Button NF. An assessment of the pattern of spontaneous eyeblink activity under the influence of topical ocular anaesthesia. Graefes Arch Clin Exp Ophthalmol 2005;243(4):306-12 (Pubitemid 40823234)
48. DoughtyMJ.Consideration of three types of spontaneous eyeblink activity in normal humans: During reading and video display terminal use, in primary gaze, and while in conversation. Optom Vis Sci 2001;78(10):712-25 (Pubitemid 33022043)
49. Collins M, Seeto R, Campbell L, Ross M. Blinking and corneal sensitivity. Acta Ophthalmol (Copenh) 1989;67(5):525-31 (Pubitemid 19283110)
50. Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res 1998;17(4): 565-96 (Pubitemid 28432981)
51. Glasgow BJ, Marshall G, Gasymov OK, Abduragimov AR, Yusifov TN, Knobler CM. Tear lipocalins: Potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci 1999;40(13):3100-7
52. Yokoi N, Yamada H, Mizukusa Y, et al. Rheology of tear film lipid layer spread in normal and aqueous tear-deficient dry eyes. Invest Ophthalmol Vis Sci 2008;49(12):5319-24
53. Goto E, Tseng SC. Differentiation of lipid tear deficiency dry eye by kinetic analysis of tear interference images. Arch Ophthalmol 2003;121(2):173-80 (Pubitemid 36184029)
54. Owens H, Phillips J. Spreading of the tears after a blink: Velocity and stabilization time in healthy eyes. Cornea 2001;20(5):484-7 (Pubitemid 32565786)
55. Brown SI, Dervichian DG. Hydrodynamics of blinking. in vitro study of the interaction of the superficial oily layer and the tears. Arch Ophthalmol 1969;82(4):541-7
56. Tsubota K, Egami F, Ohtsuki T, Shintani M. Abnormal blinking of newscasters. Lancet 1999;354(9175):308 (Pubitemid 29348750)
57. Tsubota K, Nakamori K. Effects of ocular surface area and blink rate on tear dynamics. Arch Ophthalmol 1995;113(2):155-8
58. Tsubota K, Hata S, Okusawa Y, Egami F, Ohtsuki T, Nakamori K. Quantitative videographic analysis of blinking in normal subjects and patients with dry eye. Arch Ophthalmol 1996;114(6):715-20 (Pubitemid 26197004)
59. Himebaugh NL, Begley CG, Bradley A, Wilkinson JA. Blinking and tear break-up during four visual tasks. Optom Vis Sci 2009;86(2):E106-14
60. Montes-Mico R, Caliz A, Alio JL. Wavefront analysis of higher order aberrations in dry eye patients. J Refract Surg 2004;20(3):243-7 (Pubitemid 38657014)
61. Montes-Mico R, Alio JL, Charman WN. Dynamic changes in the tear film in dry eyes. Invest Ophthalmol Vis Sci 2005;46(5):1615-9 (Pubitemid 44843594)
62. Ferrer-Blasco T, Garcia-Lazaro S, Montes-Mico R, Cervino A, Gonzalez-Meijome JM. Dynamic changes in the air-tear film interface modulation transfer function. Graefes Arch Clin Exp Ophthalmol 2010;248(1):127-32
63. Denoyer A, Rabut G, Baudouin C. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology 2012;119(9):1811-8
64. Benito A, Perez GM, Mirabet S, et al. Objective optical assessment of tear-film quality dynamics in normal and mildly symptomatic dry eyes. J Cataract Refract Surg 2011;37(8):1481-7
65. Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: Determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006;47(10):4309-15 (Pubitemid 46579353)
66. Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011;151(5):792-798.e1
67. Lemp MA, Hamill Jr JR. Factors affecting tear film breakup in normal eyes. Arch Ophthalmol 1973;89(2):103-5
68. Bron AJ, Tiffany JM, Yokoi N, Gouveia SM. Using osmolarity to diagnose dry eye: A compartmental hypothesis and review of our assumptions. Adv Exp Med Biol 2002;506(Pt B):1087-95 (Pubitemid 36308305)
69. Nichols JJ, Mitchell GL, King-Smith PE. Thinning rate of the precorneal and prelens tear films. Invest Ophthalmol Vis Sci 2005;46(7):2353-61 (Pubitemid 43119480)
70. Benedetto DA, Clinch TE, Laibson PR. In vivo observation of tear dynamics using fluorophotometry. Arch Ophthalmol 1984;102(3):410-2 (Pubitemid 14197292)
71. Craig JP, Blades K, Patel S. Tear lipid layer structure and stability following expression of the meibomian glands. Ophthalmic Physiol Opt 1995;15(6):569-74
72. Arciniega JC, Wojtowicz JC, Mohamed EM, McCulley JP. Changes in the evaporation rate of tear film after digital expression of meibomian glands in patients with and without dry eye. Cornea 2011;30(8):843-7
73. Rantamaki AH, Javanainen M, Vattulainen I, Holopainen JM. Do lipids retard the evaporation of the tear fluid Invest Ophthalmol Vis Sci 2012;53(10):6442-7
74. Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci 1997;74(1):8-13 (Pubitemid 27114503)
75. Goto E, Endo K, Suzuki A, Fujikura Y, Matsumoto Y, Tsubota K. Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2003;44(2): 533-9 (Pubitemid 36159696)
76. Mengher LS, Bron AJ, Tonge SR, Gilbert DJ. Effect of fluorescein instillation on the pre-corneal tear film stability. Curr Eye Res 1985;4(1):9-12 (Pubitemid 15162666)
77. de Paiva CS, Lindsey JL, Pflugfelder SC. Assessing the severity of keratitis sicca with videokeratoscopic indices. Ophthalmology 2003;110(6): 1102-9 (Pubitemid 36676640)
78. Gumus K, Crockett CH, Rao K, et al. Noninvasive assessment of tear stability with the tear stability analysis system in tear dysfunction patients. Invest Ophthalmol Vis Sci 2011;52(1):456-61
79. Patel S, Murray D, McKenzie A, Shearer DS, McGrath BD. Effects of fluorescein on tear breakup time and on tear thinning time. Am J Optom Physiol Opt 1985;62(3):188-90 (Pubitemid 15102619)
80. Mengher LS, Pandher KS, Bron AJ. Non-invasive tear film break-up time: Sensitivity and specificity. Acta Ophthalmol (Copenh) 1986;64(4):441-4 (Pubitemid 16016916)
81. Lemp MA. Report of the national eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J 1995;21(4):221-32
82. Abelson MB, Ousler 3rd GW, Nally LA, Welch D, Krenzer K. Alternative reference values for tear film break up time in normal and dry eye populations. Adv Exp Med Biol 2002;506(Pt B):1121-5 (Pubitemid 36308309)
83. Ousler 3rd GW, Hagberg KW, Schindelar M, Welch D, Abelson MB. The ocular protection index. Cornea 2008;27(5):509-13
84. Peng CC, Cerretani C, Braun RJ, Radke CJ. Evaporation-driven instability of the precorneal tear film. Manuscript Submitted. 2013.
85. Tsubota K, Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992;33(10):2942-50
86. Uchiyama E, Aronowicz JD, Butovich IA, McCulley JP. Increased evaporative rates in laboratory testing conditions simulating airplane cabin relative humidity: An important factor for dry eye syndrome. Eye Contact Lens 2007;33(4):174-6 (Pubitemid 47106558)
87. Rieger G. The importance of the precorneal tear film for the quality of optical imaging. Br J Ophthalmol 1992;76(3):157-8
88. Tong L, Waduthantri S, Wong TY, et al. Impact of symptomatic dry eye on vision-related daily activities: The singapore malay eye study. Eye (Lond) 2010;24(9):1486-91
89. Liu H, Thibos L, Begley CG, Bradley A. Measurement of the time course of optical quality and visual deterioration during tear breakup. Invest Ophthalmol Vis Sci 2010;51(6):3318-26
90. Tutt R, Bradley A, Begley C, Thibos LN. Optical and visual impact of tear break-up in human eyes. Invest Ophthalmol Vis Sci 2000;41(13): 4117-23
91. Kaido M, Dogru M, Ishida R, Tsubota K. Concept of functional visual acuity and its applications. Cornea 2007;26(9 Suppl 1):S29-35
92. Kaido M, Matsumoto Y, Shigeno Y, Ishida R, Dogru M, Tsubota K. Corneal fluorescein staining correlates with visual function in dry eye patients. Invest Ophthalmol Vis Sci 2011;52(13):9516-22
93. Kaido M, Ishida R, Dogru M, Tamaoki T, Tsubota K. Efficacy of punctum plug treatment in short break-up time dry eye. Optom Vis Sci 2008;85(8):758-63
94. Rolando M, Iester M, Macri A, Calabria G. Low spatial-contrast sensitivity in dry eyes. Cornea 1998;17(4):376-9 (Pubitemid 28307502)
95. Puell MC, Benitez-del-Castillo JM, Martinez-de-la-Casa J, et al. Contrast sensitivity and disability glare in patients with dry eye. Acta Ophthalmol Scand 2006;84(4):527-31
96. Huang FC, Tseng SH, Shih MH, Chen FK. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology 2002;109(10):1934-40
97. Ridder 3rd WH, LaMotte J, Hall Jr JQ, Sinn R, Nguyen AL, Abufarie L. Contrast sensitivity and tear layer aberrometry in dry eye patients. Optom Vis Sci 2009;86(9):E1059-68
98. Diaz-Valle D, Arriola-Villalobos P, Garcia-Vidal SE, et al. Effect of lubricating eyedrops on ocular light scattering as a measure of vision quality in patients with dry eye. J Cataract Refract Surg 2012;38(7): 1192-7
99. Ridder 3rd WH, Tomlinson A, Huang JF, Li J. Impaired visual performance in patients with dry eye. Ocul Surf 2011;9(1):42-55
100. Walker PM, Lane KJ, Ousler 3rd GW, Abelson MB. Diurnal variation of visual function and the signs and symptoms of dry eye. Cornea 2010;29(6):607-12
101. Tong BC, Harpole Jr DH. Molecular markers for incidence, prognosis, and response to therapy. Surg Oncol Clin N Am 2012;21(1):161-75
102. Tsubota K, Miyake M, Matsumoto Y, Shintani M. Visual protective sheet can increase blink rate while playing a hand-held video game. Am J Ophthalmol 2002;133(5):704-5 (Pubitemid 34462023)
103. Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med 1993;328(8):584 (Pubitemid 23053843)
104. Jansen ME, Begley CG, Himebaugh NH, Port NL. Effect of contact lens wear and a near task on tear film break-up. Optom Vis Sci 2010;87(5):350-7
105. Ford JG, Davis RM, Reed JW, Weaver RG, Craven TE, Tyler ME. Bilateral monocular diplopia associated with lid position during near work. Cornea 1997;16(5):525-30 (Pubitemid 27381602)
106. Shaw AJ, Collins MJ, Davis BA, Carney LG. Corneal refractive changes due to short-term eyelid pressure in downward gaze. J Cataract Refract Surg 2008;34(9):1546-53
107. Buehren T, Collins MJ, Carney L. Corneal aberrations and reading. Optom Vis Sci 2003;80(2):159-66 (Pubitemid 36222890)
108. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: A retrospective study. Cornea 2012;31(5):472-8
109. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: Estimates from the physicians? health studies. Arch Ophthalmol 2009;127(6):763-8
110. Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: Report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci 2011;52(4):1994-2005
111. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol 2009;3:405-12
112. Moss SE, Klein R, Klein BE. Incidence of dry eye in an older population. Arch Ophthalmol 2004;122(3):369-73 (Pubitemid 38314200)
113. Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci 2008;85(8):668-74
114. Zhang Y, Chen H, Wu X. Prevalence and risk factors associated with dry eye syndrome among senior high school students in a county of shandong province, china. Ophthalmic Epidemiol 2012;19(4):226-30
115. Uchino M, Nishiwaki Y, Michikawa T, et al. Prevalence and risk factors of dry eye disease in japan: Koumi study. Ophthalmology 2011;118(12):2361-7
116. Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly chinese population in Taiwan: The Shihpai eye study. Ophthalmology 2003;110(6):1096-101 (Pubitemid 36676639)
117. Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci 2006;47(4):1319-28 (Pubitemid 46780736)
118. Bunya VY, Langelier N, Chen S, Pistilli M, Vivino FB, Massaro-Giordano G. Tear osmolarity in sjögren?s syndrome. Cornea 2013 Jul;32(7):922-7
119. Gilbard JP, Farris RL. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol (Copenh) 1983;61(1):108-16 (Pubitemid 13194550)
120. Iskeleli G, Karakoc Y, Abdula A. Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn J Ophthalmol 2008;52(4):323-6
121. Fraunfelder FT, Sciubba JJ, Mathers WD. The role of medications in causing dry eye. J Ophthalmol 2012;2012:285851
122. Guillon M, Maissa C. Dry eye symptomatology of soft contact lens wearers and nonwearers. Optom Vis Sci 2005;82(9):829-34 (Pubitemid 41384109)
123. Khanal S, Tomlinson A. Tear physiology in dry eye associated with chronic GVHD. Bone Marrow Transplant 2012;47(1):115-9
124. Akpek EK, Klimava A, Thorne JE, Martin D, Lekhanont K, Ostrovsky A. Evaluation of patients with dry eye for presence of underlying sjogren syndrome. Cornea 2009;28(5):493-7
125. Abusharha AA, Pearce EI. The effect of low humidity on the human tear film. Cornea 2013;32(4):429-34
126. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136(2):318-26 (Pubitemid 36904081)
127. Galor A, Feuer W, Lee DJ, et al. Prevalence and risk factors of dry eye syndrome in a united states veterans affairs population. Am J Ophthalmol 2011;152(3):377-384.e2
128. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118(9):1264-8
129. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA 2001;286(17):2114-9 (Pubitemid 34041596)
130. Bron AJ, Yokoi N, Gafney E, Tiffany JM. Predicted phenotypes of dry eye: Proposed consequences of its natural history. Ocul Surf 2009;7(2): 78-92
131. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol 2006;124(9):1286-92 (Pubitemid 44379863)
132. Smith JA, Vitale S, Reed GF, et al. Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol 2004;122(2):151-6 (Pubitemid 38176480)
133. Nakaishi H, Yamada Y. Abnormal tear dynamics and symptoms of eyestrain in operators of visual display terminals. Occup Environ Med 1999;56(1):6-9 (Pubitemid 29103641)
134. Nakamura S, Kinoshita S, Yokoi N, et al. Lacrimal hypofunction as a new mechanism of dry eye in visual display terminal users. PLoS One 2010;5(6):e11119
135. Madden LC, Tomlinson A, Simmons PA. Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy. Eye Contact Lens 2013;39(2):169-74
136. Lee S, Lam S, Luk F. Investigation of cabin air quality in commercial aircrafts. Proc Healthy Build 2000;1:471-6
137. Wolkoff P, Nojgaard JK, Troiano P, Piccoli B. Eye complaints in the office environment: Precorneal tear film integrity influenced by eye blinking efficiency. Occup Environ Med 2005;62(1):4-12 (Pubitemid 40069453)
138. Gilbard JP, Gray KL, Rossi SR. A proposed mechanism for increased tear-film osmolarity in contact lens wearers. Am J Ophthalmol 1986;102(4):505-7 (Pubitemid 17183714)
139. Stahl U, Willcox MD, Naduvilath T, Stapleton F. Influence of tear film and contact lens osmolality on ocular comfort in contact lens wear. Optom Vis Sci 2009;86(7):857-67
140. Begley CG, Caffery B, Nichols KK, Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci 2000;77(1):40-6 (Pubitemid 30074351)
141. Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across canada. Optom Vis Sci 1997;74(8):624-31 (Pubitemid 27432771)
142. Dumbleton KA, Woods CA, Jones LW, Fonn D. The relationship between compliance with lens replacement and contact lens-related problems in silicone hydrogel wearers. Cont Lens Anterior Eye 2011;34(5):216-22
143. Dumbleton K, Woods CA, Jones LW, Fonn D. The impact of contemporary contact lenses on contact lens discontinuation. Eye Contact Lens 2013;39(1):93-9
144. Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea 2007;26(2):168-74 (Pubitemid 46168286)
145. Nichols JJ, Jones L, Nelson JD, et al. The TFOS international workshop on contact lens discomfort: Introduction. Invest Ophthalmol Vis Sci 2013;54(11). TFOS1-6
146. Campbell R, Kame G, Leach N, Paul M, White E, Zigler L. Clinical benefits of a new multipurpose disinfecting solution in silicone hydrogel and soft contact lens users. Eye Contact Lens 2012;38(2):93-101
147. Dumbleton K, Woods C, Fonn D. An investigation of the efficacy of a novel ocular lubricant. Eye Contact Lens 2009;35(3):149-55
148. Chalmers R, Long B, Dillehay S, Begley C. Improving contact-lens related dryness symptoms with silicone hydrogel lenses. Optom Vis Sci 2008;85(8):778-84
149. Johnson ME, Murphy PJ, Boulton M. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment. Optom Vis Sci 2008;85(8):750-7
150. Stahl U, Willcox M, Stapleton F. Role of hypo-osmotic saline drops in ocular comfort during contact lens wear. Cont Lens Anterior Eye 2010;33(2):68-75
151. McDonald M, D?Aversa G, Perry HD, Wittpenn JR, Donnenfeld ED, Nelinson DS. Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life. Trans Am Ophthalmol Soc 2009;107:214-21
152. Iskeleli G, Karakoç Y, Aydin O, Yetik H, Uslu H, Kizilkaya M. Comparison of tear-film osmolarity in different types of contact lenses. CLAO J 2002;28(4):174-6 (Pubitemid 38269635)
153. Martin DK. Osmolality of the tear fluid in the contralateral eye during monocular contact lens wear. Acta Ophthalmol (Copenh) 1987;65(5): 551-5 (Pubitemid 17162494)
154. Sarac O, Gurdal C, Bostanci-Ceran B, Can I. Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: Hilafilcon B hydrogel versus narafilcon A silicone hydrogel. Int Ophthalmol 2012;32(3):229-33
155. Farris RL. Tear osmolarityda new gold standard Adv Exp Med Biol 1994;350:495-503 (Pubitemid 24130678)
156. Miller WL, Doughty MJ, Narayanan S, et al. A comparison of tear volume (by tear meniscus height and phenol red thread test) and tear fluid osmolality measures in non-lens wearers and in contact lens wearers. Eye Contact Lens 2004;30(3):132-7 (Pubitemid 43196959)
157. Vishnubhatla S, Borchman D, Foulks GN. Contact lenses and the rate of evaporation measured in vitro; the influence of wear, squalene and wax. Cont Lens Anterior Eye 2012;35(6):277-81
158. Lee SY, Petznick A, Tong L. Associations of systemic diseases, smoking and contact lens wear with severity of dry eye. Ophthalmic Physiol Opt 2012;32(6):518-26
159. Nichols JJ, Bickle KM, Zink RC, Schiewe MD, Haque RM, Nichols KK. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye. Eye Contact Lens 2012;38(2):73-9
160. Forsblad-d?Elia H, Carlsten H, Labrie F, Konttinen YT, Ohlsson C. Low serum levels of sex steroids are associated with disease characteristics in primary sjogren?s syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab 2009;94(6):2044-51
161. Oncel BA, Pinarci E, Akova YA. Tear osmolarity in unilateral pseudoexfoliation syndrome. Clin Exp Optom 2012;95(5):506-9
162. Rolando M, Refojo MF, Kenyon KR. Increased tear evaporation in eyes with keratoconjunctivitis sicca. Arch Ophthalmol 1983;101(4): 557-8 (Pubitemid 13116460)
163. Khanal S, Tomlinson A, Diaper CJ. Tear physiology of aqueous deficiency and evaporative dry eye. Optom Vis Sci 2009;86(11):1235-40
164. Mathers WD, Daley TE. Tear flow and evaporation in patients with and without dry eye. Ophthalmology 1996;103(4):664-9 (Pubitemid 26114239)
165. Hamano H, Mitsunaga M. Application of an evaporimeter to the field of ophthalmology. J Japan Contact Lens Soc 1980;22:101-7
166. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with sjogren syndrome. Ophthalmology 1998;105(8):1485-8 (Pubitemid 28509770)
167. Mathers WD, Choi D. Cluster analysis of patients with ocular surface disease, blepharitis, and dry eye. Arch Ophthalmol 2004;122(11): 1700-4 (Pubitemid 39473417)
168. Tomlinson A, Doane MG, McFadyen A. Inputs and outputs of the lacrimal system: Review of production and evaporative loss. Ocul Surf 2009;7(4):186-98
169. Sommer A, Emran N. Tear production in vitamin A-responsive xerophthalmia. Am J Ophthalmol 1982;93(1):84-7 (Pubitemid 12207134)
170. Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2004;45(12): 4302-11 (Pubitemid 39564654)
171. Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res 2006;82(4):588-96 (Pubitemid 43122089)
172. Lee JH, Kim M, Im YS, Choi W, Byeon SH, Lee HK. NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells. Invest Ophthalmol Vis Sci 2008;49(5):1827-35
173. Luo L, Li DQ, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 2005;31(5):186-93 (Pubitemid 43197004)
174. Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea 2007;26(4):452-60 (Pubitemid 46684387)
175. Pflugfelder SC, Tseng SC, Yoshino K, Monroy D, Felix C, Reis BL. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology 1997;104(2):223-35 (Pubitemid 27088097)
176. Beuerman RW, Stern ME. Neurogenic inflammation: A first line of defense for the ocular surface. Ocul Surf 2005;3(4 Suppl):S203-6
177. Li N, Deng XG, He MF. Comparison of the schirmer I test with and without topical anesthesia for diagnosing dry eye. Int J Ophthalmol 2012;5(4):478-81
178. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 1995;113(10):1266-70
179. Arita R, Itoh K, Maeda S, Maeda K, Tomidokoro A, Amano S. Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye. Jpn J Ophthalmol 2010;54(5):387-91
180. Arita R, Itoh K, Maeda S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology 2009;116(11):2058-2063.e1
181. Caffery B, Simpson T, Wang S, et al. Rose bengal staining of the temporal conjunctiva differentiates sjogren?s syndrome from keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 2010;51(5):2381-7
182. Guillon M, Maissa C. Contact lens wear affects tear film evaporation. Eye Contact Lens 2008;34(6):326-30
183. Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 2003;22(7 Suppl):S19-27
184. De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci 2007;48(6):2553-60 (Pubitemid 351261205)
185. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in sjogren?s and non-sjogren?s patients with dry eye. Invest Ophthalmol Vis Sci 2002;43(8):2609-14 (Pubitemid 34809449)
186. El Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci 2009;50(8):3802-7
187. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000;41(6):1356-63 (Pubitemid 30261857)
188. Zhang X, Chen W, De Paiva CS, et al. Desiccating stress induces CD4+ T-cell-mediated sjogren?s syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-gamma. Am J Pathol 2011;179(4):1807-14
189. Yoon KC, De Paiva CS, Qi H, et al. Expression of th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: Effects of desiccating stress. Invest Ophthalmol Vis Sci 2007;48(6):2561-9 (Pubitemid 351261206)
190. Zhang X, Chen W, De Paiva CS, et al. Interferon-gamma exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci 2011;52(9):6279-85
191. Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Interferon-gamma-secreting NK cells promote induction of dry eye disease. J Leukoc Biol 2011;89(6):965-72
192. Chauhan SK, El Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to treg suppression. J Immunol 2009;182(3): 1247-52
193. Zhang X, Volpe EA, Gandhi NB, et al. NK cells promote th-17 mediated corneal barrier disruption in dry eye. PLoS One 2012;7(5):e36822
194. De Paiva CS, Chotikavanich S, Pangelinan SB, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2009;2(3):243-53
195. Schaumburg CS, Siemasko KF, De Paiva CS, et al. Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol 2011;187(7): 3653-62
196. Zheng X, de Paiva CS, Li DQ, Farley WJ, Pflugfelder SC. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Invest Ophthalmol Vis Sci 2010;51(6):3083-91
197. Redfern RL, McDermott AM. Toll-like receptors in ocular surface disease. Exp Eye Res 2010;90(6):679-87
198. Chotikavanich S, de Paiva CS, Li de Q, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 2009;50(7): 3203-9
199. Meloni M, De Servi B, Marasco D, Del Prete S. Molecular mechanism of ocular surface damage: Application to an in vitro dry eye model on human corneal epithelium. Mol Vis 2011;17:113-26
200. Smith VA, Rishmawi H, Hussein H, Easty DL. Tear film MMP accumulation and corneal disease. Br J Ophthalmol 2001;85(2):147-53 (Pubitemid 32146751)
201. Pflugfelder SC, Farley W, Luo L, et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 2005;166(1):61-71 (Pubitemid 40051660)
202. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999;40(11):2506-12 (Pubitemid 29455477)
203. Pal-Ghosh S, Pajoohesh-Ganji A, Tadvalkar G, Stepp MA. Removal of the basement membrane enhances corneal wound healing. Exp Eye Res 2011;93(6):927-36
204. Versura P, Profazio V, Schiavi C, Campos EC. Hyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro models. Invest Ophthalmol Vis Sci 2011;52(8):5488-96
205. Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci 2001;42(1):90-5 (Pubitemid 32059414)
206. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci 1997;38(7): 1458-64 (Pubitemid 27278566)
207. Baudouin C, Haouat N, Brignole F, Bayle J, Gastaud P. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol 1992;76(9): 545-9
208. Enriquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis 2010;16:862-73
209. VanDerMeid KR, Su SP, Krenzer KL, Ward KW, Zhang JZ. A method to extract cytokines and matrix metalloproteinases from schirmer strips and analyze using luminex. Mol Vis 2011;17:1056-63
210. VanDerMeid KR, Su SP, Ward KW, Zhang JZ. Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests. Invest Ophthalmol Vis Sci 2012;53(3):1512-8
211. Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 2007;26(4):431-7
212. Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci 2011;52(10):7725-30
213. Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci 2012;53(9):5443-50
214. Food and Drug Administration. Priority NDA and BLA approvals in 2002. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/How DrugsareDevelopedandApproved/DrugandBiologicApprovalReports/ PriorityNDAandBLAApprovals/ucm051251.htm. Updated 2002. Accessed 12/6, 2012.
215. Allergan.Restastis [package insert]. 2012:1e6.
216. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial. The cyclosporin A phase 2 study group. Ophthalmology 2000;107(5):967-74
217. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA phase 3 study group. Ophthalmology 2000;107(4):631-9 (Pubitemid 30191329)
218. Dastjerdi MH, Hamrah P, Dana R. High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twicedaily regimen. Cornea 2009;28(10):1091-6
219. Hong S, Kim T, Chung SH, Kim EK, Seo KY. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in sjogren?s syndrome. J Ocul Pharmacol Ther 2007;23(1):78-82 (Pubitemid 46449305)
220. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in sjogren syndrome. Ophthalmology 1999;106(4):811-6 (Pubitemid 30194327)
221. De Paiva CS, Corrales RM, Villarreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res 2006;83(3):526-35 (Pubitemid 43902774)
222. Griffin MO, Fricovsky E, Ceballos G, Villarreal F. Tetracyclines: A pleitropic family of compounds with promising therapeutic properties. review of the literature. Am J Physiol Cell Physiol 2010;299(3):C539-48
223. Dartt DA, Hodges RR, Li D, Shatos MA, Lashkari K, Serhan CN. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol 2011;186(7):4455-66
224. Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther 2010;26(5):431-9
225. Brignole-Baudouin F, Baudouin C, Aragona P, et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol 2011;89(7):e591-7
226. Rand AL, Asbell PA. Nutritional supplements for dry eye syndrome. Current opinion in ophthalmology JID-9011108. 0902.
227. Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea 2011;30(3):308-14
228. Li J, Roubeix C, Wang Y, et al. Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system. Mol Vis 2012;18:317-29
229. Hayashi Y, Ishimaru N, Arakaki R, et al. Effective treatment of a mouse model of sjogren?s syndrome with eyedrop administration of anti-CD4 monoclonal antibody. Arthritis Rheum 2004;50(9):2903-10 (Pubitemid 39209529)
230. Versura P, Profazio V, Campos EC. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res 2010;35(7):553-64
231. Jacobi C, Jacobi A, Kruse FE, Cursiefen C. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea 2011;30(12):1289-92
232. Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: Report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 2011;52(4):2006-49
233. Sullivan BD, Crews LA, Sonmez B, et al. Clinical utility of objective tests for dry eye disease: Variability over time and implications for clinical trials and disease management. Cornea 2012;31(9):1000-8
234. McCann LC, Tomlinson A, Pearce EI, Papa V. Effectiveness of artificial tears in the management of evaporative dry eye. Cornea 2012;31(1):1-5
235. Gilbard JP, Rossi SR, Azar DT, Heyda KG. Effect of punctal occlusion by freeman silicone plug insertion on tear osmolarity in dry eye disorders. CLAO J 1989;15(3):216-8 (Pubitemid 19201044)
236. Tomlinson A, Madden LC, Simmons PA. Effectiveness of dry eye therapy under conditions of environmental stress. Curr Eye Res 2013;38(2):229-36
237. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 2010;51(12): 6125-30
238. Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: Clinical implications. Acta Ophthalmol. doi: 10. 1111/aos.12012.
239. Johnson ME. The association between symptoms of discomfort and signs in dry eye. Ocul Surf 2009;7(4):199-211
240. Benjamin WJ, Hill RM. Human tears: Osmotic characteristics. Invest Ophthalmol Vis Sci 1983;24(12):1624-6 (Pubitemid 14220960)
241. Lucca JA, Nunez JN, Farris RL. A comparison of diagnostic tests for keratoconjunctivitis sicca: Lactoplate, schirmer, and tear osmolarity. CLAO J 1990;16(2):109-12 (Pubitemid 20202442)
242. See C, Bilonick RA, Feuer W, Galor A. Comparison of two methods for composite score generation in dry eye syndrome. Invest Ophthalmol Vis Sci 2013;54(9):6280-6
243. Amparo F, Jin Y, Hamrah P, Schaumberg DA, Dana R. What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease Am J Ophthalmol 2014;157(1):69-77
244. Pepose JS, Sullivan BD, Foulks G, Lemp MA. The value of tear osmolarity as a metric in evaluating the response to dry eye therapy in the clinic and in clinical trials. Am J Ophthalmology 2014;157(1):4-6 [Editorial]
245. Sullivan BD. Challenges in using signs and symptoms to evaluate new biomarkers of dry eye disease. Ocul Surf 2014;12(1):2-3 [Editorial]
246. Liu H, Begley C, Chen M, et al. A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci 2009;50(8): 3671-9
247. Begley CG, Himebaugh N, Renner D, et al. Tear breakup dynamics: A technique for quantifying tear film instability. Optom Vis Sci 2006;83(1):15-21 (Pubitemid 43361651)
248. Himebaugh NL, Nam J, Bradley A, Liu H, Thibos LN, Begley CG. Scale and spatial distribution of aberrations associated with tear breakup. Optom Vis Sci 2012;89(11):1590-600
249. Montes-Mico R, Cervino A, Ferrer-Blasco T, Garcia-Lazaro S, Madrid-Costa D. The tear film and the optical quality of the eye. Ocul Surf 2010;8(4):185-92
250. Albietz JM, Lenton LM. Management of the ocular surface and tear film before, during, and after laser in situ keratomileusis. J Refract Surg 2004;20(1):62-71 (Pubitemid 38101585)
251. Goto T, Zheng X, Klyce SD, et al. Evaluation of the tear film stability after laser in situ keratomileusis using the tear film stability analysis system. Am J Ophthalmol 2004;137(1):116-20 (Pubitemid 38045196)
252. Konomi K, Chen LL, Tarko RS, et al. Preoperative characteristics and a potential mechanism of chronic dry eye after LASIK. Invest Ophthalmol Vis Sci 2008;49(1):168-74
253. Dooley I, D?Arcy F, O?Keefe M. Comparison of dry-eye disease severity after laser in situ keratomileusis and laser-assisted subepithelial keratectomy. J Cataract Refract Surg 2012;38(6):1058-64
254. Quinto GG, Camacho W, Behrens A. Postrefractive surgery dry eye. Curr Opin Ophthalmol 2008;19(4):335-41
255. Khanal S, Tomlinson A, Esakowitz L, et al. Changes in corneal sensitivity and tear physiology after phacoemulsification. Ophthalmic Physiol Opt 2008;28(2):127-34 (Pubitemid 351388686)
256. Woodward MA, Randleman JB, Stulting RD. Dissatisfaction after multifocal intraocular lens implantation. J Cataract Refract Surg 2009;35(6):992-7
257. Donnenfeld ED, Solomon R, Roberts CW, Wittpenn JR, McDonald MB, Perry HD. Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation. J Cataract Refract Surg 2010;36(7):1095-100
258. Pflugfelder SC, Baudouin C. Challenges in the clinical measurement of ocular surface disease in glaucoma patients. Clin Ophthalmol 2011;5: 1575-83
259. Stewart WC, Stewart JA, Nelson LA. Ocular surface disease in patients with ocular hypertension and glaucoma. Curr Eye Res 2011;36(5): 391-8
260. Baudouin C. Effects of topical drug preservatives on the tear film and ocular surface. TFOS Abstracts 2010:48
261. Wong TT, Zhou L, Li J, et al. Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest Ophthalmol Vis Sci 2011;52(10):7385-91
262. Labbe A, Terry O, Brasnu E, Van Went C, Baudouin C. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Cornea 2012;31(9):994-9
263. Neves Mendes CR, Hida RY, Kasahara N. Ocular surface changes in eyes with glaucoma filtering blebs. Curr Eye Res 2012;37(4):309-11
264. Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol 1996;122(6):818-24 (Pubitemid 26412428)
265. Danjo Y, Hamano T. Observation of precorneal tear film in patients with sjogren?s syndrome. Acta Ophthalmol Scand 1995;73(6):501-5 (Pubitemid 26059860)
266. Hosaka E, Kawamorita T, Ogasawara Y, et al. Interferometry in the evaluation of precorneal tear film thickness in dry eye. Am J Ophthalmol 2011;151(1):18-23.e1
267. Ring MH, Rabensteiner DF, Horwath-Winter J, Boldin I, Horantner R, Haslwanter T. Introducing a new parameter for the assessment of the tear film lipid layer. Invest Ophthalmol Vis Sci 2012;53(10):6638-44
268. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004; 23(8):762-70 (Pubitemid 39447304)
269. Kaido M, Ishida R, Dogru M, Tsubota K. The relation of functional visual acuity measurement methodology to tear functions and ocular surface status. Jpn J Ophthalmol 2011;55(5):451-9
270. Savini G, Barboni P, Zanini M. Tear meniscus evaluation by optical coherence tomography. Ophthalmic Surg Lasers Imaging 2006;37(2): 112-8
271. Savini G, Goto E, Carbonelli M, Barboni P, Huang D. Agreement between stratus and visante optical coherence tomography systems in tear meniscus measurements. Cornea 2009;28(2):148-51
272. Uchida A, Uchino M, Goto E, et al. Noninvasive interference tear meniscometry in dry eye patients with sjogren syndrome. Am J Ophthalmol 2007;144(2):232-7
273. Nguyen P, Huang D, Li Y, et al. Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease. Cornea 2012;31(6):680-5
274. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001;42(10):2283-92 (Pubitemid 32848857)
275. Srinivasan S, Thangavelu M, Zhang L, Green KB, Nichols KK. iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Invest Ophthalmol Vis Sci 2012;53(8):5052-9
276. Kaufman HE. The practical detection of MMP-9 diagnoses ocular surface disease and may help prevent its complications. Cornea 2013; 32(2):211-6
277. Sambursky R, Davitt 3rd WF, Latkany R, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 2013;131(1):24-8
278. Chiva A. Electrophoresis of tear proteins as a new diagnostic tool for two high risk groups for dry eye: Computer users and contact lens wearers. J Med Life 2011;4(3):228-33
279. Advanced tear diagnostics. http://teardiagnostics.com/doctors/ lactoferrin/ded/. Updated 2013. Accessed May 7, 2013.
280. Kijlstra A. The role of lactoferrin in the nonspecific immune response on the ocular surface. Reg Immunol 1990;3(4):193-7
281. Goren MB, Goren SB. Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol 1988;106(5):570-4 (Pubitemid 18260811)
282. Pult H, Nichols JJ. A review of meibography. Optom Vis Sci 2012;89(5):E760-9
283. Srinivasan S, Menzies K, Sorbara L, Jones L. Infrared imaging of meibomian gland structure using a novel keratograph. Optom Vis Sci 2012;89(5):788-94
284. Arita R. Validity of noninvasive meibography systems: Noncontact meibography equipped with a slit-lamp and a mobile pen-shaped meibograph. Cornea 2013;(32 Suppl 1):S65-70
285. Kojima T, Matsumoto Y, Dogru M, Tsubota K. The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease. Mol Vis 2010;16:2457-64
286. Wakamatsu TH, Sato EA, Matsumoto Y, et al. Conjunctival in vivo confocal scanning laser microscopy in patients with sjogren syndrome. Invest Ophthalmol Vis Sci 2010;51(1):144-50
287. Villani E, Beretta S, De Capitani M, Galimberti D, Viola F, Ratiglia R. In vivo confocal microscopy of meibomian glands in sjogren?s syndrome. Invest Ophthalmol Vis Sci 2011;52(2):933-9
288. Hwang HS, Shin JG, Lee BH, Eom TJ, Joo CK. In vivo 3D meibography of the human eyelid using real time imaging fourier-domain OCT. PLoS One 2013;8(6):e67143
289. Pult H, Riede-Pult BH, Nichols JJ. Relation between upper and lower lids? meibomian gland morphology, tear film, and dry eye. Optom Vis Sci 2012;89(3):E310-5
290. Guillemin I, Begley C, Chalmers R, Baudouin C, Arnould B. Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: Revisiting the standards. Ocul Surf 2012;10(2):84-99
291. Viso E, Rodriguez-Ares MT, Abelenda D, Oubina B, Gude F. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of spain. Invest Ophthalmol Vis Sci 2012;53(6):2601-6
292. Begley CG, Caffery B, Chalmers RL, Mitchell GL. Dry Eye Investigation (DREI) Study Group. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea 2002;21(7):664-70
293. Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in north america. Cornea 2001;20(6):610-8 (Pubitemid 32706197)
294. McMonnies CW, Ho A. Patient history in screening for dry eye conditions. J Am Optom Assoc 1987;58(4):296-301
295. Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 2007;15(5): 389-93 (Pubitemid 350035478)
296. U.S.Department of Health and Human Services, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for industry. patient-reported outcome measures: Use in medical product development to support labeling claims. Available at: Http://www.fda.gov/ downloads/Drugs/Guidances/UCM193282.pdf. Accessed Jan 20, 2014.
297. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 2001;119(7):1050-8 (Pubitemid 32652197)
298. Rjagopalan K, Abetz L, Mertzanis P, et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health 2005;8(2):168-74 (Pubitemid 40525378)